Catalent
Catalent is a global leader in drug development and distribution, providing opportunities for career growth in a dynamic environment. The company collaborates with pharmaceutical and healthcare companies to bring new medicines from development through to market, producing billions of doses annually.
Headquarters
Tampa, Florida, United States
Company Size
10001+ employees
Founded
2007
Catalent delivers end-to-end pharma solutions as a trusted CDMO, advancing drug development and manufacturing worldwide. Partner with us today!
Novo's troubled Indiana plant claims another victim as FDA rejects Incyte's lung cancer application
3 days ago
Inspection issues remain at Catalent Indiana plant, pharma companies say
1 day ago
Incyte’s Lung Cancer Expansion Bid Thwarted by Issues at Novo’s Catalent-Acquired Site
3 days ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Catalent.
Catalent didn’t post a salary, so this is our estimate from similar listings.
Catalent to lay off at least 96 employees in Maryland amid ongoing workforce reductions
3 weeks ago
Pharmaziepraktikum in der Forschung und Entwicklung
AbbVie
Associate Director, Formulation and Drug Product Development
Dyne Therapeutics
Pharmaziepraktikum in der Forschung und Entwicklung
AbbVie
Technicien de fabrication H/F - Service Production Pharmaceutique - Horaires 5*8 - CDD
State of North Carolina
Biologics Drug Product Lead (R&D) (all genders) (full-time, permanent)
AbbVie
Director, CMC Project Development
AbbVie